The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients

BACKGROUND: Recent randomized trials have not found that polymyxin B hemoperfusion (PMX-HP) improves outcomes for patients with sepsis. However, it remains unclear whether the therapy could provide benefit for highly selected patients. Monocyte human leukocyte antigen (mHLA-DR) expression, a critica...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Crit Care
Главные авторы: Srisawat, Nattachai, Tungsanga, Somkanya, Lumlertgul, Nuttha, Komaenthammasophon, Chalermchai, Peerapornratana, Sadudee, Thamrongsat, Nicha, Tiranathanagul, Khajohn, Praditpornsilpa, Kearkiat, Eiam-Ong, Somchai, Tungsanga, Kriang, Kellum, John A.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204024/
https://ncbi.nlm.nih.gov/pubmed/30367647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-018-2077-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы